Research ExplorerJournalsCTS-CLIN TRANSL SCI Publications

CTS-CLIN TRANSL SCI - CTS-Clinical and Translational Science

1 - 5 out of 5Page size: 50

Publications

  1. 2023

  2. Protocol of the IntenSify-Trial: An open-label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab-paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy

    Hohmann, N., Sprick, M. R., Pohl, M., Ahmed, A., Burhenne, J., Kirchner, M., Le Cornet, L., Kratzmann, M., Hajda, J., Stenzinger, A., Steindorf, K., Delorme, S., Schlemmer, H-P., Riethdorf, S., van Schaik, R., Pantel, K., Siveke, J., Seufferlein, T., Jäger, D., Haefeli, W. E., Trumpp, A. & Springfeld, C., 12.2023, In: CTS-CLIN TRANSL SCI. 16, 12, p. 2483-2493 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 2022

  4. Vericiguat in combination with isosorbide mononitrate in patients with chronic coronary syndromes: The randomized, phase Ib, VISOR study

    Boettcher, M., Mikus, G., Trenk, D., Düngen, H-D., Donath, F., Werner, N., Karakas, M., Besche, N., Schulz-Burck, D., Gerrits, M., Hung, J. & Becker, C., 05.2022, In: CTS-CLIN TRANSL SCI. 15, 5, p. 1204-1214 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. 2021

  6. Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies

    Wirtz, T. H., Loosen, S. H., Schulze-Hagen, M., Gorgulho, J., Kandler, J., Joerdens, M., Demir, M., Mohr, R., Bruners, P., Kuhl, C., Trautwein, C., Berres, M-L., Tacke, F., Luedde, T. & Roderburg, C., 09.2021, In: CTS-CLIN TRANSL SCI. 14, 5, p. 1853-1863 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration

    Kim, A., Grover, A., Hammon, K., de Hart, G., Slasor, P., Cherukuri, A., Ajayi, T., Jacoby, D., Schulz, A., Specchio, N., de Los Reyes, E., Gissen, P. & Henshaw, J. W., 03.2021, In: CTS-CLIN TRANSL SCI. 14, 2, p. 635-644 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. 2020

  9. Early M-protein Dynamics Predicts Progression-Free Survival in Patients With Relapsed/Refractory Multiple Myeloma

    Yan, X., Xu, X. S., Weisel, K. C., Mateos, M-V., Sonneveld, P., Dimopoulos, M. A., Usmani, S. Z., Bahlis, N. J., Puchalski, T., Ukropec, J., Bellew, K., Ming, Q., Sun, S. & Zhou, H., 11.2020, In: CTS-CLIN TRANSL SCI. 13, 6, p. 1345-1354 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review